Completed × Has results × Magnetic Resonance Spectroscopy × Clear all Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Phase 2/3 Completed
159 enrolled 17 charts
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Phase 3 Completed
546 enrolled 29 charts
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Phase 1 Completed
12 enrolled 12 charts
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Phase 3 Completed
190 enrolled 12 charts
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
Phase 2 Completed
27 enrolled 15 charts
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Phase 2 Completed
91 enrolled 14 charts
Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
Phase NA Completed
6 enrolled 8 charts
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
Phase 2 Completed
77 enrolled 17 charts
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
Phase 2 Completed
30 enrolled 12 charts
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
Phase 3 Completed
163 enrolled 3 charts
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
Phase 2 Completed
43 enrolled 19 charts
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
31 enrolled 20 charts
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
Phase 3 Completed
1 enrolled 1 chart
Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA
Phase NA Completed
25 enrolled 7 charts
AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
Phase 2 Completed
4 enrolled 7 charts
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
Phase 2 Completed
78 enrolled 15 charts
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Phase 2 Completed
56 enrolled 14 charts
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
18 enrolled 12 charts
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Phase 1 Completed
20 enrolled 7 charts
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Phase 1/2 Completed
27 enrolled 16 charts
Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone
Phase 2 Completed
17 enrolled 8 charts
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Phase 2 Completed
51 enrolled 14 charts
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Phase 1 Completed
58 enrolled 17 charts
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Phase 2 Completed
47 enrolled 14 charts
PET Scan in Treating Patients With Metastatic Prostate Cancer
Phase NA Completed
173 enrolled 9 charts
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
Phase 2 Completed
86 enrolled 16 charts
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Phase 2 Completed
127 enrolled 12 charts
PAINT
Phase 2 Completed
35 enrolled 13 charts
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Phase 3 Completed
235 enrolled 12 charts
Osteosarcoma
Phase 2 Completed
32 enrolled 11 charts
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors
Phase 1 Completed
9 enrolled 6 charts
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
Phase 1/2 Completed
5 enrolled 6 charts
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Phase NA Completed
28 enrolled 17 charts
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Phase 3 Completed
53 enrolled 14 charts
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Phase 2 Completed
257 enrolled 13 charts
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Phase 2/3 Completed
122 enrolled 8 charts
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
Phase 2 Completed
20 enrolled 10 charts
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Phase 2 Completed
21 enrolled 10 charts
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Phase 2 Completed
46 enrolled 12 charts
Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
Phase 2 Completed
29 enrolled 10 charts
TEPARF
Phase NA Completed
89 enrolled 8 charts
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery
Phase 2/3 Completed
74 enrolled 9 charts
Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study
Phase NA Completed
57 enrolled 8 charts
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Phase 2/3 Completed
61 enrolled 10 charts
Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors
Phase NA Completed
42 enrolled 8 charts
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT
Phase 2 Completed
68 enrolled 8 charts
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Phase NA Completed
20 enrolled 12 charts
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Phase 2 Completed
164 enrolled 7 charts
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Phase NA Completed
10 enrolled 3 charts
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Phase NA Completed
15 enrolled 17 charts